Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Equivalence of Julphar Insulin R vs Huminsulin Normal
NCT02634515Phase 1Completed
- Sponsor
- Julphar
- Start
- Dec 2014
- Primary completion
- Feb 2015
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of human insulin in diabetes mellitus (DM) (2 arms), sponsored by Julphar. Primary endpoints: Area under the serum insulin concentration time curve from 0 to 12 hours, Maximum serum insulin concentration at 12 hours and 2 more. Started Dec 2014; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT02634515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634515.